5 Best Biotech Stocks Under $5

4. Arbutus Biopharma Corporation (NASDAQ:ABUS)

Number of Hedge Fund Holders: 5

Price as of October 14, 2021: $4.15

Arbutus Biopharma Corporation (NASDAQ:ABUS) is a Canadian biotech company that is focused on developing a treatment for hepatitis B infection. Around its main drug, AB-729, Arbutus Biopharma Corporation (NASDAQ:ABUS) is working on mid-stage trials with three different partners and expects results from these trials in the second half of 2021 and early 2022.

Arbutus Biopharma Corporation (NASDAQ:ABUS) was also in the limelight after it won a patent infringement case against Moderna, Inc. (NASDAQ:MRNA) for the use of its lipid nanoparticles that help in the delivery of drugs to certain cells. This delivery system has been employed in the development of the COVID-19 vaccine by Moderna. The win can open the door to potential royalties from the vaccine that is expected to generate annual revenues of $20 billion for Moderna. 

The company was covered by B. Riley Securities with a Buy rating and a price target of $7.